Roundup Lawsuit Update: Settlements & Eligibility

Thousands of people who used Roundup or other glyphosate products later received a diagnosis of Non-Hodgkin Lymphoma. Many of them are agricultural workers, landscapers, groundskeepers, and home gardeners who never expected a common weed killer to change their lives.

This guide explains the current status of the Roundup lawsuit, the proposed nationwide settlement, who may qualify, typical compensation ranges, and the practical steps to protect your rights. You will find clear information on exposure requirements, medical criteria, court developments, and how to move forward if you or a loved one has been affected.

What Is the Roundup Lawsuit About?

Roundup is a widely used herbicide that contains glyphosate. For decades it has been sprayed on farms, lawns, parks, and gardens. Starting in the mid-2010s, large numbers of people diagnosed with Non-Hodgkin Lymphoma began filing lawsuits against Monsanto (now owned by Bayer). They alleged that the company failed to warn users about cancer risks linked to long-term exposure.

The litigation centers on product liability and toxic tort claims. Plaintiffs argue that glyphosate and Roundup formulations can increase the risk of certain blood cancers, particularly Non-Hodgkin Lymphoma and its subtypes. Bayer has consistently maintained that Roundup is safe when used as directed and points to regulatory findings supporting that position.

Juries have returned mixed results. Some trials produced large plaintiff verdicts. Others favored the defense. Bayer has already paid more than $10 billion to resolve earlier waves of claims. Tens of thousands of cases remained active when the company announced a new proposed class settlement in February 2026.

Current Status of the Bayer Monsanto Litigation

In February 2026 Bayer and plaintiffs’ counsel announced a proposed $7.25 billion class settlement in Missouri state court (King v. Monsanto). The agreement aims to resolve both current and future Non-Hodgkin Lymphoma claims tied to Roundup exposure that occurred before February 17, 2026.

A Missouri judge granted preliminary approval in March 2026. The final fairness hearing has been rescheduled several times and was most recently set for mid-September 2026. Opt-out and objection deadlines passed in early June 2026. As of early September 2026 the settlement has not yet received final approval and remains subject to court review and possible appeals.

Separately, the U.S. Supreme Court issued a significant ruling in June 2026 in Monsanto Co. v. Durnell. By a 7-2 vote the Court held that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts many state-law failure-to-warn claims when the EPA has approved a pesticide label without a cancer warning. This decision strengthens Bayer’s legal position in remaining individual cases that rely primarily on failure-to-warn theories.

Approximately 3,900 cases remain pending in the federal multidistrict litigation in California. Additional cases continue in state courts. The proposed class settlement is designed to cover the large majority of current and future Non-Hodgkin Lymphoma claims arising from pre-February 2026 exposure.

Who Qualifies for a Roundup Lawsuit or Settlement Claim?

Eligibility focuses on three core elements: exposure to Roundup or glyphosate-based products, a qualifying diagnosis of Non-Hodgkin Lymphoma, and timely action under applicable rules.

Exposure Requirements

You generally need to show exposure in the United States before February 17, 2026. Qualifying exposure includes:

• Applying the product yourself
• Purchasing or paying for the product or its application
• Participating in, directing, or observing application
• Having other reason to know you were exposed

The settlement distinguishes between occupational and residential claimants.

Occupational claimants typically need more than 80 hours of exposure in an agricultural, industrial, turf, or ornamental capacity. They also need to show that in at least one year the relevant work provided more than 50 percent of their income or more than $15,000. Documentary proof such as employment records, tax documents, or payroll records is usually required.

Residential claimants (home gardeners and other non-occupational users) generally need at least 16 hours or 10 lifetime days of exposure. Attestation is often sufficient for residential claims.

Home gardeners can and do qualify. Regular backyard or property use over multiple seasons can meet the threshold.

Qualifying Medical Diagnosis

The primary qualifying condition is Non-Hodgkin Lymphoma (NHL), including both aggressive (fast-growing) and indolent (slow-growing) subtypes. Common subtypes that have appeared in claims include diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and others. Certain related blood cancers may also be considered depending on the specific criteria applied by the claims administrator or court.

You will need medical records confirming the diagnosis and the date it was made.

Derivative and Representative Claimants

Spouses, parents, dependent children, and other individuals with legal standing (such as estate representatives for deceased claimants) may also participate under defined rules.

Average Roundup Lawsuit Settlement Amounts and Payout Tiers

The proposed 2026 class settlement uses a nine-tier system. Awards depend on three main factors: occupational versus residential exposure, age at diagnosis, and whether the NHL is aggressive or indolent.

Approximate average Program Awards are:

• Occupational, under age 60, aggressive NHL: $165,000
• Occupational, ages 60-77, aggressive NHL: $105,000
• Occupational, under age 60, indolent NHL: $85,000
• Occupational, ages 60-77, indolent NHL: $60,000
• Residential, under age 60, aggressive NHL: $40,000
• Residential, ages 60-77, aggressive NHL: $30,000
• Residential, under age 60, indolent NHL: $25,000
• Residential, ages 60-77, indolent NHL: $20,000
• Any claimant age 78 or older: $10,000

Individual awards can range from roughly 80 percent to 120 percent of the tier average based on claim-specific factors such as strength of exposure proof, treatment intensity, and stage of disease. The highest standard awards can therefore approach $198,000 before any additional funds.

A Quick-Pay option exists for certain residential and older claimants. These fixed amounts are lower (roughly $6,000 to $14,500) but paid faster. Accepting Quick-Pay generally means forgoing a full Program Award.

Additional compensation may be available through special funds for extraordinary medical circumstances (such as death before age 78, organ transplant, or advanced-stage disease) or for residential claimants with unusually heavy exposure.

These figures apply to the proposed class settlement. Individual lawsuits that went to trial or settled outside the class structure have produced both higher and lower results. Past individual settlements and verdicts have varied widely.

Scientific Findings and Regulatory Background

The scientific and regulatory picture remains contested.

In 2015 the International Agency for Research on Cancer (IARC), part of the World Health Organization, classified glyphosate as “probably carcinogenic to humans” (Group 2A). That classification rested on limited evidence in humans (mainly Non-Hodgkin Lymphoma) and sufficient evidence in experimental animals.

The U.S. Environmental Protection Agency has consistently reached a different conclusion. EPA assessments have stated that glyphosate is not likely to be carcinogenic to humans when used according to label directions. As of 2026 the agency is conducting an updated human health risk assessment, with completion anticipated in late 2026. EPA released an open literature search document for public comment in August 2026.

Other regulators, including those in the European Union, Canada, and Japan, have generally supported continued registration of glyphosate with certain restrictions. California lists glyphosate under Proposition 65 as a chemical known to the state to cause cancer.

Courts have allowed juries to hear evidence from both sides. The 2026 Supreme Court decision in Durnell limits certain failure-to-warn theories but does not eliminate all potential claims.

Statute of Limitations for a Roundup Lawsuit

Every state sets its own deadline for filing a personal injury or product liability claim. Most range from two to four years, though some are shorter or longer.

In toxic exposure cases the “discovery rule” often applies. The clock typically starts when the person discovers, or reasonably should have discovered, both the injury and its possible connection to Roundup. For many claimants that date is the cancer diagnosis or the later moment they learned of the alleged link.

Statutes of repose in some states can cut off claims after a fixed number of years from the date of last exposure or sale of the product, regardless of discovery.

Because deadlines vary and can be complex, anyone considering a claim should consult an attorney promptly. Missing a filing deadline can permanently bar recovery.

How to File a Roundup Cancer Lawsuit or Settlement Claim

If the proposed class settlement receives final approval, the process will generally work as follows:

1. Monitor the official settlement website (currently associated with WeedKillerClass.com) for the opening of registration and claims.
2. Subclass 1 members (already diagnosed) will typically need to register within a set window after final approval and submit a complete claim package within a further deadline.
3. Subclass 2 members (exposed but not yet diagnosed) can file later if they receive an NHL diagnosis, generally within six years of diagnosis or before the sixteenth annual payment date, whichever comes first.
4. Gather medical records confirming the diagnosis and date, plus any available proof of exposure (employment records, purchase receipts, photos, witness statements, or personal declarations).
5. Submit the claim through the designated administrator.

For individuals who opted out of the class or whose claims fall outside the settlement, traditional individual lawsuits remain an option in appropriate jurisdictions, subject to the statute of limitations and the impact of the Durnell decision.

Working with an experienced mass-tort or toxic-tort attorney is strongly recommended. Counsel can evaluate eligibility, gather evidence, calculate potential recovery, and handle the procedural requirements. Most such lawyers work on a contingency fee basis, meaning they are paid only if compensation is recovered.

Common Pitfalls to Avoid

• Waiting too long and missing a statute of limitations or settlement deadline.
• Assuming home use automatically disqualifies a claim (it does not).
• Failing to preserve medical and exposure records.
• Accepting a Quick-Pay award without understanding that it usually closes the door to a larger Program Award.
• Relying solely on general internet information instead of personalized legal advice.

What Compensation May Cover

Successful claims or settlement awards can address:

• Past and future medical expenses
• Lost wages and diminished earning capacity
• Pain and suffering
• In some cases, loss of consortium for spouses

Punitive damages are generally released under the class settlement for those who remain in it. Individuals who properly exit the settlement under its terms may retain certain rights to pursue compensatory (but usually not punitive) damages in court.

Frequently Asked Questions

Who qualifies for a Roundup lawsuit in 2026?
People exposed to Roundup or glyphosate products in the United States before February 17, 2026, who later received a diagnosis of Non-Hodgkin Lymphoma (or certain related conditions) may qualify, provided their claim is timely under state law or settlement rules. Both occupational and residential users can qualify.

What is the average Roundup lawsuit settlement amount?
Under the proposed class settlement, tier averages range from about $10,000 to $165,000, with individual awards adjustable between roughly 80 percent and 120 percent of the average. Higher awards typically go to younger occupational claimants with aggressive NHL. Individual lawsuits outside the class have produced a wider range of results.

Can home gardeners file a Roundup lawsuit?
Yes. Residential users who meet the exposure threshold (generally 16 hours or 10 lifetime days) and have a qualifying diagnosis can participate in the settlement or, in some cases, pursue individual claims.

How do I file a Roundup cancer lawsuit?
For the class settlement, wait for the claims process to open after final court approval, then register and submit documentation through the official administrator. For individual cases, contact a qualified attorney who can evaluate your situation and file in the appropriate court before the statute of limitations expires.

What is the statute of limitations for a Roundup lawsuit?
It varies by state, commonly two to four years. The discovery rule often starts the clock at diagnosis or when the connection to Roundup was (or should have been) discovered. Consult a lawyer promptly for your specific state’s rules.

Does the EPA still say glyphosate is safe?
Yes. The EPA’s longstanding position is that glyphosate is not likely carcinogenic to humans when used as directed. The agency is updating its human health risk assessment, with completion expected in late 2026. IARC continues to classify glyphosate as probably carcinogenic.

What happens if I already opted out of the settlement?
You generally retain the right to pursue an individual lawsuit, subject to the statute of limitations and the legal effect of the 2026 Supreme Court decision on failure-to-warn claims. Some individuals who previously opted out have sought to revoke those elections.

You May Also Like: LifeStance Health Lawsuit: $3.02M Settlement Guide